Dr. Srikanth Rajagopal
Managing Partner and Vice President, Commercial Consulting Services
Doc is an experienced management consultant, client partner and practice leader, with close to 20 years of experience selling, leading & delivering a range of product and portfolio strategy, transaction advisory, evidence generation, pricing and market access, commercial strategy and transformation, and business innovation engagements for biopharmaceutical industry clients and their investors across the US, Europe, Asia-Pacific and Japan.
He believes in a structured, collaborative, expertise-based approach to problem-solving and solution development. Doc partners with colleagues across Clarivate to harness our deep expertise in global healthcare systems, policy, drug development and approval, therapy areas and indications, business development and licensing, pricing and reimbursement systems and processes, customer engagement models and data and advanced analytics to deliver exceptional, impactful outcomes for our clients.
He previously led Clarivate Europe, Asia-Pacific and Japan Commercial Consulting business, and has held positions of increasing responsibility at global consulting firms such as Guidehouse, IQVIA and Strategic Decisions Group (SDG).
By way of academic qualifications, Doc holds an MBA from the Indian Institute of Management, Ahmedabad and an MBBS (MD equivalent) from the University of Mumbai.
Latest news
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…
Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources
Clarivate Nexus integrates academic content and services into the AI tools increasingly used by students and researchers, helping libraries and institutions remain central to trusted scholarship. LONDON, UK — January…
